Find clinical trials for Eczema in Dallas, TX
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Eczema trials near Dallas, TX, USA:
applied emollient, in adult subjects with moderate to severe eczema. Approximately 120 adult participants will be enrolled and randomized in...
Phase 2
Irving, Texas, United States
The purpose of this study is to evaluate the efficacy and safety of different dose regimens of IMG-007, compared to placebo.
Phase 2
Southlake, Texas, United States and 20 other locations
the treatment of adults with moderate to severe Atopic Dermatitis (Eczema). OpSCF will be compared to a placebo.OpSCF or placebo will be adm...
Phase 2
Frisco, Texas, United States of America and 21 other locations
This is a double-blind, placebo-controlled study where subjects are participating for approximately 36 to 40 weeks. The study compares how well BFB75...
Phase 2
Southlake, Texas, United States and 6 other locations
This study will evaluate the efficacy and safety of different doses of EVO756 in adults with moderate to severe atopic dermatitis.
Phase 2
Lewisville, Texas, United States and 23 other locations
This is a phase IIa, randomized, double-blind, placebo-controlled, multi-center proof-of-concept (POC) study in subjects with moderate to severe Atop...
Phase 2
Frisco, Texas, United States and 27 other locations
The purpose of this global Phase 3 clinical study is to investigate the safety and efficacy of tapinarof cream, 1% in participants ages 3 months to 2...
Phase 3
Dallas, Texas, United States and 48 other locations
The purpose of this study is to measure how well taking lebrikizumab alone works for participants with fewer places on the body with eczema ...
Phase 4
Mansfield, Texas, United States and 74 other locations
The primary objective of the study is to assess the long-term safety of dupilumab in pediatric participants with AD.The secondary objectives of the s...
Phase 3
Fort Worth, Texas, United States and 83 other locations
This study evaluates ATI-045 versus placebo in patients with Moderate-to-Severe Atopic Dermatitis.
Phase 2
Dallas, Texas, United States and 57 other locations
Clinical trials
Research sites
Resources
Legal